AQST

Aquestive Therapeutics, Inc.

5 transactions on file, per SEC Form 4 filings.

Korczynski Sherry

Chief Commercial Officer · 2026-09-09

Option exercise

$23K

Korczynski Sherry

Chief Commercial Officer · 2026-09-09

Sold

$46K

Boyd Peter E.

Chief People Officer · 2026-09-09

X-InTheMoney

$2K

Barber Daniel

President and CEO · 2026-09-08

X-InTheMoney

$88K

Jung Cassie

Chief Operating Officer · 2026-09-03

X-InTheMoney

$4K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is AQST actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.